Study unravels new insights into a Parkinson's disease protein

Alpha-synuclein is known to form abnormal clumps in the brains of patients with Parkinson's, but scientists are still trying to understand how and why this happens.

The new study explores alpha-synuclein's basic properties, with a focus on a section of the protein known as the non-amyloidal component (NAC). The research was done on fruit fly larvae that were genetically engineered to produce both normal and mutated forms of human alpha-synuclein.

The study, led by University at Buffalo biologist Shermali Gunawardena, was published on Jan. 10 in the journalFrontiers in Cellular Neuroscience.

Some key findings:

• The NAC region appears to aid alpha-synuclein in moving through pathways called axons that run from one area of a neuron to another. When the NAC region was missing, alpha-synuclein did not move within axons.
• α-突触核蛋白,错过了南京地区的可能help to prevent unwanted aggregates of the protein. In experiments, Gunawardena's team showed that it's possible -- at least in fruit flies -- to prevent some key problems that occur when too much alpha-synuclein is produced: clumping of the protein; abnormalities in the structure of synapses, which form connections between neurons; and a decrease in the speed at which larvae crawl. The scientists found that when the larvae are engineered to produce both excess alpha-synuclein and a version of alpha-synuclein with the NAC region missing, the larvae crawl normally, the protein doesn't aggregate, and the synapses are normal.

"We show that in fruit fly larvae, we're able to prevent some problems mimicking symptoms of Parkinson's disease, such as accumulation of alpha-synuclein in neurons," says Gunawardena, PhD, associate professor of biological sciences in the UB College of Arts and Sciences.

"Our work highlights a potential early treatment strategy for Parkinson's disease that would leverage the use of deletion of the NAC region," Gunawardena adds. "One reason this study is important is because it shows rescue of alpha-synuclein aggregates, synaptic morphological defects and locomotion defects seen in Parkinson's disease in the context of a whole organism."